Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial

Rationale: The aromatase inhibitor anastrozole blocks the conversion of androgens to estrogen and blunts pulmonary hypertension in animals, but its efficacy in treating patients with pulmonary arterial hypertension (PAH) is unknown. Objectives: We aimed to determine the safety and efficacy of anastr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Am J Respir Crit Care Med
Main Authors: Kawut, Steven M., Archer-Chicko, Christine L., DeMichele, Angela, Fritz, Jason S., Klinger, James R., Ky, Bonnie, Palevsky, Harold I., Palmisciano, Amy J., Patel, Mamta, Pinder, Diane, Propert, Kathleen J., Smith, K. Akaya, Stanczyk, Frank, Tracy, Russell, Vaidya, Anjali, Whittenhall, Mary E., Ventetuolo, Corey E.
Format: Artigo
Sprog:Inglês
Udgivet: American Thoracic Society 2017
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5328182/
https://ncbi.nlm.nih.gov/pubmed/27602993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201605-1024OC
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker